Allianz Asset Management GmbH - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 154 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 7.07 and the average weighting 0.1%.

Quarter-by-quarter ownership
Allianz Asset Management GmbH ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$210,728
+105.1%
42,400
+103.8%
0.00%
Q1 2023$102,752
-54.5%
20,800
-0.5%
0.00%
Q3 2022$226,000
-56.2%
20,900
-53.8%
0.00%
Q2 2022$516,000
+24.9%
45,2850.0%0.00%
Q1 2022$413,000
-49.6%
45,285
-17.0%
0.00%
-100.0%
Q4 2021$819,000
+99.8%
54,585
+241.9%
0.00%
Q3 2021$410,000
-1.4%
15,9650.0%0.00%
Q2 2021$416,000
-38.4%
15,965
-10.8%
0.00%
-100.0%
Q3 2020$675,000
-19.4%
17,895
-8.4%
0.00%0.0%
Q2 2020$837,00019,5380.00%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
VV Manager LLC 1,798,163$76,997,00067.53%
Wildcat Capital Management, LLC 1,515,524$64,895,00022.42%
TPG Group Holdings (SBS) Advisors, Inc. 19,716,306$844,252,00014.91%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 1,279,281$54,779,0007.69%
Coastal Bridge Advisors, LLC 463,117$19,831,0006.33%
DSAM Partners (London) Ltd 235,098$10,067,0002.63%
Casdin Capital, LLC 625,000$26,763,0001.58%
Alpine Global Management, LLC 150,000$6,423,0001.13%
Perceptive Advisors 1,543,790$66,105,0001.07%
Avoro Capital Advisors LLC 1,128,594$48,326,0000.96%
View complete list of ALLOGENE THERAPEUTICS INC shareholders